Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Americo Fernandes

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|April 3, 2015
A multi-center screening trial of rasagiline in patients with amyotrophic lateral sclerosis: Possible mitochondrial biomarker target engagementZachary Macchi, Yunxia Wang, Dan Moore, et al.
Behavioural Neurology|December 6, 2018
Longitudinal Screening Detects Cognitive Stability and Behavioral Deterioration in ALS PatientsSusan Woolley, Ray Goetz, Pam Factor-Litvak, et al.
Behavioural Neurology|December 31, 2019
Corrigendum to "Longitudinal Screening Detects Cognitive Stability and Behavioral Deterioration in ALS Patients"Susan Woolley, Ray Goetz, Pam Factor-Litvak, et al.
Muscle & Nerve|September 8, 2018
Rasagiline for amyotrophic lateral sclerosis: A randomized, controlled trialJeffrey M Statland, Dan Moore, Yunxia Wang, et al.
Muscle & Nerve|June 3, 2020
Clinical features of LRP4/agrin-antibody-positive myasthenia gravis: A multicenter studyMichael H Rivner, Brandy M Quarles, Jin-Xiu Pan, et al.
JAMA Network Open|February 17, 2025
Efficacy and Safety of Zilucoplan in Amyotrophic Lateral Sclerosis: A Randomized Clinical TrialSabrina Paganoni, Christina N Fournier, Eric A Macklin, et al.
JAMA|March 11, 2025
CNM-Au8 in Amyotrophic Lateral Sclerosis: The HEALEY ALS Platform Trial, James D Berry, Nicholas J Maragakis, et al.
JAMA|March 11, 2025
Pridopidine in Amyotrophic Lateral Sclerosis: The HEALEY ALS Platform Trial, Jeremy M Shefner, Björn Oskarsson, et al.
JAMA Neurology|March 11, 2025
Verdiperstat in Amyotrophic Lateral Sclerosis: Results From the Randomized HEALEY ALS Platform Trial, Jinsy Andrews, Sabrina Paganoni, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|April 3, 2015
A multi-center screening trial of rasagiline in patients with amyotrophic lateral sclerosis: Possible mitochondrial biomarker target engagementZachary Macchi, Yunxia Wang, Dan Moore, et al.
Behavioural Neurology|December 6, 2018
Longitudinal Screening Detects Cognitive Stability and Behavioral Deterioration in ALS PatientsSusan Woolley, Ray Goetz, Pam Factor-Litvak, et al.
Behavioural Neurology|December 31, 2019
Corrigendum to "Longitudinal Screening Detects Cognitive Stability and Behavioral Deterioration in ALS Patients"Susan Woolley, Ray Goetz, Pam Factor-Litvak, et al.
Muscle & Nerve|September 8, 2018
Rasagiline for amyotrophic lateral sclerosis: A randomized, controlled trialJeffrey M Statland, Dan Moore, Yunxia Wang, et al.
Muscle & Nerve|June 3, 2020
Clinical features of LRP4/agrin-antibody-positive myasthenia gravis: A multicenter studyMichael H Rivner, Brandy M Quarles, Jin-Xiu Pan, et al.
JAMA Network Open|February 17, 2025
Efficacy and Safety of Zilucoplan in Amyotrophic Lateral Sclerosis: A Randomized Clinical TrialSabrina Paganoni, Christina N Fournier, Eric A Macklin, et al.
JAMA|March 11, 2025
CNM-Au8 in Amyotrophic Lateral Sclerosis: The HEALEY ALS Platform Trial, James D Berry, Nicholas J Maragakis, et al.
JAMA|March 11, 2025
Pridopidine in Amyotrophic Lateral Sclerosis: The HEALEY ALS Platform Trial, Jeremy M Shefner, Björn Oskarsson, et al.
JAMA Neurology|March 11, 2025
Verdiperstat in Amyotrophic Lateral Sclerosis: Results From the Randomized HEALEY ALS Platform Trial, Jinsy Andrews, Sabrina Paganoni, et al.
Pageof 3